Five Prime Therapeutics, Inc. Shares Authorized
Five Prime Therapeutics, Inc. had Shares Authorized of 100.00 million shares as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2021-03-22
- 2020-12-31: Common Stock, Shares Authorized 100.00M shares.
- 2020-09-30: Common Stock, Shares Authorized 100.00M shares.
- 2020-06-30: Common Stock, Shares Authorized 100.00M shares.
- 2020-03-31: Common Stock, Shares Authorized 100.00M shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2020-12-31 | 100.00M shares 10-K · filed 2021-03-22 |
| 2020-09-30 | 100.00M shares 10-Q · filed 2020-11-03 |
| 2020-06-30 | 100.00M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 100.00M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 100.00M shares 10-K · filed 2021-03-22 |
| 2019-09-30 | 100.00M shares 10-Q · filed 2019-11-06 |
| 2019-06-30 | 100.00M shares 10-Q · filed 2019-08-08 |
| 2019-03-31 | 100.00M shares 10-Q · filed 2019-05-09 |
| 2018-12-31 | 100.00M shares 10-K · filed 2020-02-27 |
| 2018-09-30 | 100.00M shares 10-Q · filed 2018-11-06 |
| 2018-06-30 | 100.00M shares 10-Q · filed 2018-08-08 |
| 2018-03-31 | 100.00M shares 10-Q · filed 2018-05-08 |
| 2017-12-31 | 100.00M shares 10-K · filed 2019-02-26 |
| 2017-09-30 | 100.00M shares 10-Q · filed 2017-11-06 |
| 2017-06-30 | 100.00M shares 10-Q · filed 2017-08-08 |
| 2017-03-31 | 100.00M shares 10-Q · filed 2017-05-05 |
| 2016-12-31 | 100.00M shares 10-K · filed 2018-02-27 |
| 2015-12-31 | 100.00M shares 10-K · filed 2017-02-24 |
| 2014-12-31 | 100.00M shares 10-K · filed 2016-03-11 |
| 2013-12-31 | 100.00M shares 10-K · filed 2015-03-18 |
| 2012-12-31 | 193.00M shares 10-K · filed 2014-03-26 |